AMRI receives NIH contract for clinical drug product

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jan, 2015

Singapore: Clinical research firm, AMRI, has received a 10-year federal contract award from the National Institutes of H...Read more

Singapore start-up progresses in Alzheimer's drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Sep, 2014

Singapore: Singapore start-up and Scotland based TauRx Therapeutics is progressing in its two Phase III clinical trials ...Read more

Novartis: Lucentis reduces AMD blindness by 50%

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209...Read more

Genovate, ScinoPharm co-develop Hep B Drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2013

Singapore: Taiwan based Genovate Biotechnology and ScinoPharm have jointly developed the highly potent oral generic drug...Read more

Roche acquires respiratory therapy firm at $8.3 bn

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2014

Singapore: Global biopharmaceutical company, Roche, has acquired InterMune, a biotechnology company focused on the resea...Read more

Neurocrine Biosciences collaborates with Mitsubishi Tanabe Pharma

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2015

Nasdaq-listed Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement for the develop...Read more

Daiichi Sankyo initiates TaNeDS drug discovery program in Europe

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2015

Tokyo: Japan's Daiichi Sankyo Company Limited has announced details of the application for its Take a New Challenge for ...Read more

Aussie firm gets FDA green flag for oncology drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 02 Apr, 2015

Singapore: Australia biotech firm, Prescient Therapeutics, a clinical stage oncology company, has secured agreement from...Read more

Pomalidomide Celgene gets EU nod for multiple myeloma

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 04 Jun, 2013

Singapore: European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing a...Read more

Spinifex capitalizes on pain management market

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2012

Realizing the need for improved therapies in the highly unmet field of pain management, Australia-based Spinifex has bee...Read more

Gilead's Viread patent revoked in China

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2013

Singapore: China's State Intellectual Property Office (SIPO) has yanked the patent for Gilead Sciences popular HIV and h...Read more

Companion diagnostic drug for prostate cancer from Japan

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 Mar, 2015

Singapore: Japan's Tokai Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel therapi...Read more

Biogen, Elan drug effective for multiple sclerosis

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2013

Singapore: A study conducted on Biogen and Elan Pharmaceuticals's natalizumab has been shown to be effective for treatin...Read more

Roche, AstraZeneca form firm to share R&D data

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jun, 2013

Singapore: Roche and AstraZeneca entered into a collaboration to share early research data generated by Matched Molecula...Read more

EMA says no to risky schizophrenia drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

Singapore: European Medicines Agency's (EMA) Committee for Medicinal Product for Human Use (CHMP) has issued a negative ...Read more

HUYA partners with Shanghai Zhangjiang Biotech

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2013

Singapore: HUYA Bioscience International has entered into a collaborative partnership with Shanghai Zhangjiang Biotech a...Read more

Zydus, Pieris to develop anticalin-based protein drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2013

Singapore: India-based Zydus Cadila and Pieris, a next generation therapeutic protein R&D company, have entered int...Read more

Eli Lilly and Kowa Pharma report positive results of PREVAIL study

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

Singapore: Kowa Pharmaceuticals America and Eli Lilly and Company revealed results of the PREVAIL study that was held in...Read more